Oct 18 (Reuters) - Recce Pharmaceuticals Ltd (RCE) :
- RECCE 327 SARS-COV-2 STUDY UPDATE
- AUSTRALIAN SARS-COV-2 STUDIES CONCLUDES BY MUTUAL AGREEMENT
- RECCE 327 (R327) SHOWN TO SIGNIFICANTLY REDUCE SARS-COV-2 IN HAMSTERS
News: RCE Recce Pharmaceuticals Updates on Recce 327 Sars-Cov-2 Study
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
-0.010(2.15%) |
Mkt cap ! $103.1M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 46.5¢ | 45.5¢ | $217.5K | 469.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 118398 | 45.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 56300 | 1 |
View Market Depth
| Last trade - 10.19am 10/07/2024 (20 minute delay) ? |
| RCE (ASX) Chart |